Skip to main content

Table 3 Clinical and demographic data of the patient cohort used in the Meta-analysis

From: Microrna expression signatures predict patient progression and disease outcome in pediatric embryonal central nervous system neoplasms

 

N

All

Males

Females

Unknown gender

Medulloblastoma

ATRT

Germinoma

Controls

Mean age (years)

STDEV AGE

Mean Age (weeks)

STDEV age

Meta-analysis

ALL

161

       

4.15

11.91

226.32

574.91

 

MALES

82

       

3.85

13.76

210.26

663.33

 

FEMALES

46

       

1.09

2.43

76.16

122.39

 

UNKNOWN GENDER

32

       

9.20

14.00

476.79

672.56

 

MEDULLOBLASTOMA

19

8

7

4

    

6.89

4.13

366.95

198.43

 

ATRT

8

1

3

4

    

2.23

2.18

142.95

104.49

 

GERMINOMA

12

0

0

12

    

11.15

3.08

571.00

147.76

 

CONTROLS

121

73

36

12

    

3.04

13.43

169.45

647.52

 

FETAL

76

40

32

4

0

0

0

76

0.00

0.00

18.39

3.41

 

INFANT

19

15

4

0

1

2

0

16

0.56

0.54

62.67

25.71

 

CHILD

40

9

10

21

15

6

9

10

5.82

3.52

315.53

168.84

 

ADOLESCENT

6

3

0

3

3

0

3

0

14.07

1.57

711.54

75.34

 

ADULT

5

2

0

3

0

0

0

5

56.48

29.58

2746.94

1419.60

 

%

ALL

MALES

FEMALES

UNKNOWN GENDER

MEDULLOBLASTOMA

ATRT

GERMINOMA

CONTROLS

    
 

ALL

100.00%

           
 

MALES

50.93%

           
 

FEMALES

28.57%

           
 

UNKNOWN GENDER

19.88%

           
 

MEDULLOBLASTOMA

11.80%

4.97%

4.35%

2.48%

        
 

ATRT

4.97%

0.62%

1.86%

2.48%

        
 

GERMINOMA

7.45%

0.00%

0.00%

7.45%

        
 

CONTROLS

75.16%

45.34%

22.36%

7.45%

        
 

FETAL

47.20%

24.84%

19.88%

2.48%

0.00%

0.00%

0.00%

47.20%

    
 

INFANT

11.80%

9.32%

2.48%

0.00%

0.62%

1.24%

0.00%

9.94%

    
 

CHILD

24.84%

5.59%

6.21%

13.04%

9.32%

3.73%

5.59%

6.21%

    
 

ADOLESCENT

3.73%

1.86%

0.00%

1.86%

1.86%

0.00%

1.86%

0.00%

    
 

ADULT

3.11%

1.24%

0.00%

1.86%

0.00%

0.00%

0.00%

3.11%